Enzalutamide is an androgen receptor inhibitor used in the treatment of metastatic castration-resistant prostate cancer. It works by binding to androgen receptors and inhibiting androgen signaling, which is necessary for the growth of prostate cancer cells.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Enzalutamide and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Enzalutamide impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Enzalutamide-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
Chemical Name: 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-(3-fluoro-4-(methylcarbamoyl)phenyl)benzamide
Chemical Name: 4-(3-(1-(4-cyano-3-(trifluoromethyl)phenyl)-3-methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile